Cost-Effectiveness Analysis of talazoparib Maintenance Treatment for patients with germline BRCA1/2 mutated HER2-negative advanced breast cancer in China and the US
Preprint in Research Square (October 2023)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Preprint in Research Square (October 2023)
Article in Frontiers in Oncology (August 2023)
Article in BMC Health Services Research (December 2022)